aspirin has been researched along with Leukemia, Myeloid, Acute in 10 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As compared with hydroxyurea plus aspirin, anagrelide plus aspirin was associated with increased rates of arterial thrombosis (P=0." | 5.11 | Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. ( Bareford, D; Buck, G; Campbell, PJ; East, CL; Green, AR; Grigg, AP; Harrison, CN; Reilly, JT; Revell, P; van der Walt, JD; Wheatley, K; Wilkins, BS; Woodcock, BE, 2005) |
| " An algorithm for the treatment of patients with erythremia is proposed along with recommendations on the use of aspirin, hydroxyurea, alpha-interpheron, and imatinib." | 4.88 | [True polycythemia: current views of pathogenesis, diagnostics and treatment]. ( Bakhteeva, TD; Kalinkina, NV; Skliannaia, EV; Taradin, GG; Vatutin, NT, 2012) |
| "Essential thrombocythemia is a chronic myeloproliferative neoplasm characterized by sustained thrombocytosis, bone marrow megakaryocytic hyperplasia and an increased risk of thrombosis and hemorrhage." | 2.49 | [Treatment of essential thrombocythemia]. ( Alvarez-Larrán, A; Besses, C; Cervantes, F, 2013) |
| "An increased incidence of acute granulocytic leukemia (AGL) has been noted in patients receiving such therapy." | 1.27 | Acute granulocytic leukemia following systemic lupus erythematosus. ( Goldberg, J; Paolozzi, FP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Larrán, A | 1 |
| Cervantes, F | 1 |
| Besses, C | 1 |
| Vatutin, NT | 1 |
| Taradin, GG | 1 |
| Bakhteeva, TD | 1 |
| Kalinkina, NV | 1 |
| Skliannaia, EV | 1 |
| Harrison, CN | 1 |
| Campbell, PJ | 1 |
| Buck, G | 1 |
| Wheatley, K | 1 |
| East, CL | 1 |
| Bareford, D | 1 |
| Wilkins, BS | 1 |
| van der Walt, JD | 1 |
| Reilly, JT | 1 |
| Grigg, AP | 1 |
| Revell, P | 1 |
| Woodcock, BE | 1 |
| Green, AR | 1 |
| Barbui, T | 1 |
| Finazzi, G | 1 |
| Weiss, JR | 1 |
| Baker, JA | 1 |
| Baer, MR | 1 |
| Menezes, RJ | 1 |
| Nowell, S | 1 |
| Moysich, KB | 1 |
| Boccaccio, P | 1 |
| Ghio, R | 1 |
| Ratti, M | 1 |
| Casciaro, S | 1 |
| Rattenni, S | 1 |
| Sergnese, G | 1 |
| Nakai, K | 1 |
| Tajima, K | 1 |
| Kishimoto, Y | 1 |
| Katsura, K | 1 |
| Kawamura, M | 1 |
| Yamamoto, Y | 1 |
| Hanada, M | 1 |
| Zen, K | 1 |
| Amakawa, R | 1 |
| Fujimoto, M | 1 |
| Fukuhara, S | 1 |
| Dawson, AA | 1 |
| Paolozzi, FP | 1 |
| Goldberg, J | 1 |
| Bray, B | 1 |
| Dehorne, M | 1 |
| Guimbretière, J | 1 |
3 reviews available for aspirin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
[Treatment of essential thrombocythemia].
Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Cell Transformation, Neoplastic; Disease Progress | 2013 |
[True polycythemia: current views of pathogenesis, diagnostics and treatment].
Topics: Age Factors; Algorithms; Antineoplastic Agents; Aspirin; Benzamides; Combined Modality Therapy; Hema | 2012 |
[Disseminated intravascular coagulation. II. Therapeutic problems].
Topics: Antifibrinolytic Agents; Antithrombin III Deficiency; Anuria; Aprotinin; Aspirin; Blood Transfusion; | 1982 |
1 trial available for aspirin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aspirin; Drug Therapy, Combination; Female; F | 2005 |
6 other studies available for aspirin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
When and how to treat essential thrombocythemia.
Topics: Antineoplastic Agents; Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxyurea; Leukemia | 2005 |
Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia.
Topics: Acetaminophen; Adult; Aged; Aspirin; Case-Control Studies; Dose-Response Relationship, Drug; Female; | 2006 |
[Bone marrow transplantation-associated thrombotic microangiopathy manifested by visual disturbance].
Topics: Adult; Aspirin; Bone Marrow Transplantation; Dipyridamole; Female; Humans; Leukemia, Myeloid, Acute; | 2000 |
Drug-induced haematological disease.
Topics: Anemia; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Aspirin; Bone Marrow Diseases; Hemato | 1979 |
Acute granulocytic leukemia following systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aspirin; Cyclophosphamide; Cytarabine; Humans; Immunosuppressi | 1985 |
[Drug allergies and leukemias. Preliminary study].
Topics: Aged; Aminopyrine; Analgesics; Anti-Bacterial Agents; Antibodies; Antigen-Antibody Complex; Antigens | 1969 |